EU Panel Recommends Marketing Authorization for Dengue Vaccine
The EMA CHMP has recommended marketing authorization for a dengue tetravalent vaccine against dengue virus serotypes 1, 2, 3, and 4. International Approvals …read more
The EMA CHMP has recommended marketing authorization for a dengue tetravalent vaccine against dengue virus serotypes 1, 2, 3, and 4. International Approvals …read more